SF3B1 and B-cell chronic lymphocytic leukemia: Yin et al. revealed a contributory driving role of mutated SF3B1 in CLL progression, as the combination of SF3B1 mutation and ATM deletion restricted to B-cells resulted in CLL-like disease in mouse model due to increased genomic instability [25].